We are live on ! Find out more
NFGH

Nan Fung Group Holdings Portfolio holdings

AUM $121M
1-Year Est. Return 56.89%
This Fund
S&P 500
This Quarter Est. Return
+27.23%
1 Year Est. Return
+56.89%
3 Year Est. Return
+244.35%
5 Year Est. Return
+210.19%
10 Year Est. Return
–
AUM
$157M
AUM Growth
+$11.1M
Cap. Flow
-$4.85M
Cap. Flow %
-3.1%
Top 10 Hldgs %
84.67%
Holding
43
New
2
Increased
3
Reduced
4
Closed
4

Top Buys

Rank Stock Value
1
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$3.23M
2
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
+$2.29M
3
EXAI
Exscientia Plc American Depositary Shares
EXAI
+$836K
4
STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
+$198K
5
RLMD icon
Relmada Therapeutics
RLMD
+$156K

Top Sells

Rank Stock Value
1
HRMY icon
Harmony Biosciences
HRMY
+$6.1M
2
SNOW icon
Snowflake
SNOW
+$2.67M
3
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$1.65M
4
TRDA icon
Entrada Therapeutics
TRDA
+$406K
5
HCP
HashiCorp, Inc. Class A Common Stock
HCP
+$383K

Sector Composition

Rank Sector Weight
1 Healthcare 98.8%
2 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACAD icon
26
Acadia Pharmaceuticals
ACAD
$5.03B
$491K 0.31%
29,984
– –
ASND icon
27
Ascendis Pharma A/S
ASND
$16.8B
$430K 0.27%
4,168
– –
ALXO icon
28
ALX Oncology
ALXO
$290M
$401K 0.26%
41,950
– –
ARGX icon
29
argenx
ARGX
$54.1B
$392K 0.25%
1,110
– –
OTIC
30
DELISTED
Otonomy, Inc.
OTIC
$251K 0.16%
851,000
-80
-0% -$70
RLMD icon
31
Relmada Therapeutics
RLMD
$527M
$209K 0.13%
+5,642
New +$156K
RETA
32
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$208K 0.13%
8,265
– –
KYNB
33
Kyntra Bio
KYNB
$29.4M
$192K 0.12%
590
– –
AFMD
34
DELISTED
Affimed
AFMD
$167K 0.11%
8,117
– –
KOD icon
35
Kodiak Sciences
KOD
$2.84B
$152K 0.1%
19,622
– –
ABCL icon
36
AbCellera Biologics
ABCL
$2.12B
$124K 0.08%
12,521
– –
SYBX
37
DELISTED
Synlogic
SYBX
$65K 0.04%
4,576
– –
CERS icon
38
Cerus
CERS
$474M
$51K 0.03%
14,172
– –
NVTA
39
DELISTED
Invitae Corporation
NVTA
$28K 0.02%
11,337
– –
SNOW icon
40
Snowflake
SNOW
$115B
– –
-19,210
Closed -$2.67M
SRPT icon
41
Sarepta Therapeutics
SRPT
$1.77B
– –
-3,917
Closed -$294K
HCP
42
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
– –
-13,001
Closed -$383K
TCRR
43
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
– –
-19,335
Closed -$56K
1
2

Similar funds

MAM
Mirabaud Asset Management London, United Kingdom $121M AUM 20.69% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
CCM
Candelo Capital Management New York $121M AUM 113.39% 1-Year Est. Return
CCM
CFO Capital Management Fairfield, Connecticut $121M AUM
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
MW
Merited Wealth North Bay Village, Florida $121M AUM

Nan Fung Group Holdings's Q3 2022 Portfolio in Review

As of Q3 2022, Nan Fung Group Holdings held 43 positions worth $157M, up 7.6% from $146M the previous quarter. Its ten largest holdings account for 85% of the portfolio.

Nan Fung Group Holdings withdrew a net $4.85M in Q3 2022, closing 4 positions and reducing 4 holdings. Its most notable exit was Snowflake, an estimated $2.67M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 97% a quarter earlier, followed by Technology.

Against the trend, Nan Fung Group Holdings opened a new position in Chinook Therapeutics, Inc. Common Stock worth $2.24M.

  • Nan Fung Group Holdings's largest Q3 2022 buy was Chinook Therapeutics, Inc. Common Stock: 113,950 shares worth $2.24M.
  • Nan Fung Group Holdings added most to Karuna Therapeutics, Inc. Common Stock in Q3 2022, an estimated $3.23M increase.
  • Nan Fung Group Holdings's biggest Q3 2022 reduction was Harmony Biosciences, cutting an estimated $6.1M.
  • Nan Fung Group Holdings fully exited Snowflake in Q3 2022, selling an estimated $2.67M.
  • Nan Fung Group Holdings's ten largest holdings make up 85% of its $157M portfolio in Q3 2022.
  • Nan Fung Group Holdings opened 2 new positions and closed 4 in Q3 2022.
  • Nan Fung Group Holdings's portfolio value rose 7.6% quarter-over-quarter to $157M.

Based on Nan Fung Group Holdings's 13F filing for Q3 2022, filed 10 Nov 2022.